All stock lists
Unlock the score
AbCellera Biologics Inc. (NASDAQ:ABCL)
CA · Delayed Price · Currency is USD
Healthcare · Biotechnology
12.14+0.33 (+2.75%)
Market cap
$3.94B
Insider Score
Analyst consensus
Listed since
Dec 11, 2020
Website
Insider Score
/ 100
ABCL Insider Score
AbCellera Biologics Inc. has a live Insider Score.
Scored on 4 qualifying trades from 3 insiders in the last 90 days.
ABCL Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 4.05 M | 8.31 M | 44.85 M | 8.96 M | 17.08 M | 4.24 M |
| Revenue Growth (YoY) | -76.29 % | 96.34 % | 788.18 % | 37.62 % | 133.29 % | -57.45 % |
| Cost of Revenue | 0.00 | 8.65 M | 7.92 M | 0.00 | 0.00 | 0.00 |
| Gross Profit | 4.05 M | -340.00 K | 36.93 M | 8.96 M | 17.08 M | 4.24 M |
| SG&A Expense | 13.85 M | 10.52 M | 15.42 M | 24.96 M | 21.99 M | 19.07 M |
| R&D Expense | 45.99 M | 46.66 M | 50.09 M | 55.03 M | 39.21 M | 42.50 M |
| Operating Expenses | 66.83 M | 57.18 M | 65.52 M | 85.23 M | 66.67 M | 66.89 M |
| Operating Income | -62.78 M | -57.52 M | -28.58 M | -76.28 M | -49.59 M | -62.66 M |
| Pretax Income | -58.97 M | -49.54 M | -19.50 M | -68.77 M | -36.34 M | -52.98 M |
| Tax Provision | -3.54 M | -6.37 M | -10.55 M | -11.65 M | -1.62 M | -7.36 M |
| Net Income | -55.43 M | -43.16 M | -8.95 M | -57.12 M | -34.73 M | -45.62 M |
| EPS (Basic) | -0.18 | -0.14 | -0.03 | -0.19 | -0.12 | -0.15 |
| EPS (Diluted) | -0.18 | -0.14 | -0.03 | -0.19 | -0.12 | -0.15 |
| Shares Outstanding | 305.56 M | 303.07 M | 298.71 M | 298.88 M | 298.51 M | 297.69 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.